neobookRx
DrugsLevel 4 LocalisationS2DOU · VAGEML

Povidone Iodine

Iodine compoundAntiseptic

Indications

Registered South African indications:

  • Vaginitis

Cautions

Contraindications

  • Hypersensitivity to the active ingredient or any of its excipients

Cautions

  • Pregnancy
  • Breastfeeding
  • Renal impairment
  • Hepatic impairment
  • Large doses
  • Prolonged duration
  • Burns
  • Thyroid dysfunction
  • Children

Adult dosage

Forms avail. in SA and covered in this monograph: dou, gel

Vaginitis
-Candida albicans
-Trichomonas vaginalis
-Mixed infections
-Non-specific infections

  • Topical (gel): 1 full applicator, dly at night; Followed by morning douching
  • Topical (dou): Add 10ml to applicator bottle, fill with lukewarm water to indicated filling line, dly; Treatment duration: 7-14 days

See additional prescribing points for administration directions


If further therapy is required, the prescribed regimen should be continued through the next two menstrual cycles and the patient reviewed every 14 days


Cleansing and deodorising

  • Topical (dou): Add 5ml to applicator bottle, fill with lukewarm water to indicated filling line, 1-2/weekly

See additional prescribing points for administration directions

Paediatric dosage

No information available

Special populations

Pregnancy

  • Caution
  • Povidone-iodine for vaginal use is not recommended for use during pregnancy, due to systemic absorption of the povidone-iodine that occurs when its applied on the vaginal mucosa. Increased systemic concentrations of povidone-iodine have been observed following vaginal use of the agent including presence in amniotic fluid. Risk to the foetus cannot be excluded, with hypothyroidism reported in a newborn after topical use of povidone-iodine before childbirth

Breastfeeding

  • Caution
  • Iodine has been found to be excreted in breastmilk, after application of topical povidone-iodine. Risk-benefit assessment is recommended before use of povidone-iodine is considered in breastfeeding women

Renal Impairment

Hepatic Impairment

Elderly

Porphyria Information

Drugs in Sport

  • Permitted - No warnings

Adverse reactions

Skin and Subcutaneous Tissue Disorders

  • Oedema
  • Irritation
  • Pruritus
  • Rash

Immune, Blood and Lymphatic System Disorders

  • Hypersensitivity

Interactions

  • BCG 
  • Sodium picosulfate
  • Taurolidine

Monitoring

None routine

Prescribing points

Administration directions - therapeutic douche 

  • Carefully insert the applicator high into the vagina without causing discomfort 
  • Expel as much cleansing liquid as possible by applying gentle pressure on the sides of the squeeze bottle, allowing the solution to run freely from the vagina 
  • Remove the applicator from the vagina allowing air to enter the squeeze bottle, so that it regains its original shape
  • Reinsert the applicator into the vagina squeezing once again to cleanse the vagina thoroughly
  • Repeat until all the douche solution has been used
  • Finally rinse away the excess solution from around the vagina
  • Pat dry the vaginal area with a clean cloth or paper towel
  • Rinse clean the empty bottle and applicator in warm water and store for further use

Mechanism of action

Povidone-iodine is a multivalent broad spectrum local antiseptic having bactericidal and fungicidal properties. The effect on vegetative cells of various bacteria and fungi is due to the liberation of free iodine from the complex. Many viruses, protozoa, yeasts, cysts and spores are also susceptible.

Dosage forms

  • Douche
  • Vaginal gel

Formulation

Vaginal gel (per 5g) 0.5g

  • Betadine vaginal gel (Mundipharm) originator

Douche (per 100ml) 10g

  • Betadine douche (Mundipharm) originator
  • Betadine douche refill (Mundipharm) originator

Also available in the following forms: Cream, ointment, surgical scrub, solution, shampoo and oral antiseptic

References

1. SAMF_12th Edition_Page 219 2. https://drive.google.com/drive/folders/1OsU7s7tSIzS6_jLtbu8AM5PDOE2OQtQV (23/01/1987_Adcock_Betadine_vag gel_Intekom) 3. https://drive.google.com/drive/folders/1OsU7s7tSIzS6_jLtbu8AM5PDOE2OQtQV (23/09/1993_Adcock_Betadine_douche_Intekom) 4. https://www.uptodate.com/contents/povidone-iodine-topical-drug-information? source=search_result&search=povidine%20iodine&selectedTitle=1~150 5. NAPOS The Drug Database for Acute Porphyria: G01AX11 Povidone-iodine; Accessed online 09 Jan 2019 [http://www.drugs-porphyria.org/languages/UnitedKingdom/s3.php?atc_code=G01AX11&l=gbr] 6. South African Institute for Drug-Free Sport; Betadine; Accessed online 09 Jan 2019 [http://www.drugfreesport.org.za/online-medication-check/] **No SPC available

Brands & products

3 products · cached snapshot
Trade names (1)
  • Betadine

DOUDouche· 2 products

from R251.92
ProductStrengthPackApplicantMin price
Betadine Douche Refill10 g/100ml250Mundipharma (Pty) LtdR251.92
Betadine Douche10 g/100ml250Mundipharma (Pty) LtdR330.48

VAGVaginal gel· 1 product

from R296.60
ProductStrengthPackApplicantMin price
Betadine Vaginal Gel0.5 g/5g100iNova Pharmaceuticals (Pty) LtdR296.60

Medical aid coverage

data not yet integrated
Discovery Health
not yet integrated
  • Comprehensive Series—
  • Executive Plan—
  • KeyCare Series—
  • Priority Series—
  • Saver Series—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

Bonitas Medical Fund
not yet integrated
  • BonClassic—
  • BonComprehensive—
  • BonEssential—
  • BonFit Select—
  • BonSave—
  • BonStart—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

GEMS — Government Employees Medical Scheme
not yet integrated
  • Beryl—
  • Emerald—
  • Onyx—
  • Ruby—
  • Sapphire—
  • Tanzanite One—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

POLMED — Police Medical Aid Scheme
not yet integrated
  • Aquarium Option—
  • Efficiency Option—
  • Marine Option—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

Cited in 13 documents

NeoHealth® ID 15129 · updated 11/2/2022